Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe (CROSBI ID 619365)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Mocroft, A. ; Ryom, L. ; Lapadula, G. ; Reiss, P. ; Blaxhult, A. ; Furrer, H. ; Kutsyna, G. ; Gatell, J. ; Begovac, Josip ; Kirk, O. et al. The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe // Journal of the International AIDS Society. 2014. str. 19561-19561

Podaci o odgovornosti

Mocroft, A. ; Ryom, L. ; Lapadula, G. ; Reiss, P. ; Blaxhult, A. ; Furrer, H. ; Kutsyna, G. ; Gatell, J. ; Begovac, Josip ; Kirk, O. ; Lundgren, J.

engleski

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe

Proteinuria (PTU) is an important marker for the development and progression of renal disease, cardiovascular disease and death, but there is limited information about the prevalence and factors associated with confirmed PTU in predominantly white European HIV+ persons, especially in those with an estimated glomerular filtration rate (eGFR) of 60 mL/min/1.73 m(2). Baseline was defined as the first of two consecutive dipstick urine protein (DPU) measurements during prospective follow-up >1/6/2011 (when systematic data collection began). PTU was defined as two consecutive DUP >1+ (>30 mg/dL) >3 months apart ; persons with eGFR <60 at either DPU measurement were excluded. Logistic regression investigated factors associated with PTU. A total of 1, 640 persons were included, participants were mainly white (n=1, 517, 92.5%), male (n=1296, 79.0%) and men having sex with men (n=809 ; 49.3%). Median age at baseline was 45 (IQR 37-52 years), and CD4 was 570 (IQR 406-760/mm(3)). The median baseline date was 2/12 (IQR 11/11-6/12), and median eGFR was 99 (IQR 88- 109 mL/min/1.73 m(2)). Sixty-nine persons had PTU (4.2%, 95% CI 3.2-4.7%). Persons with diabetes had increased odds of PTU, as were those with a prior non-AIDS (1) or AIDS event and those with prior exposure to indinavir. Among females, those with a normal eGFR (>90) and those with prior abacavir use had lower odds of PTU (Figure 1). One in 25 persons with eGFR>60 had confirmed proteinuria at baseline. Factors associated with PTU were similar to those associated with CKD. The lack of association with antiretrovirals, particularly tenofovir, may be due to the cross- sectional design of this study, and additional follow-up is required to address progression to PTU in those without PTU at baseline. It may also suggest other markers are needed to capture the deteriorating renal function associated with antiretrovirals may be needed at higher eGFRs. Our findings suggest PTU is an early marker for impaired renal function.

HIV infection; Renal function

DOI: 10.7448/IAS.17.4.19561

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

19561-19561.

2014.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Podaci o skupu

The HIV Drug Therapy Glasgow Congress

predavanje

01.01.2014-01.01.2014

Glasgow, Ujedinjeno Kraljevstvo

Povezanost rada

Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita

Indeksiranost